Remove Development Remove Genetics Remove Scientist
article thumbnail

Tome Biosciences debuts with $213M and a new way to edit the genome

Bio Pharma Dive

Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.

Genomics 328
article thumbnail

Scientists discover non-invasive approach for cancer therapy

Pharmaceutical Technology

Scientists at the Northwestern University in Illinois, US, have discovered a non-invasive approach to isolate a tumour’s attack cells from blood, rather than from tumours. Scientists removed and processed melanoma tumours, and found tumour-infiltrating lymphocytes (TILs) within them.

Scientist 244
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leveraging Genetic Testing for Enrolling Rare Disease Trials

Worldwide Clinical Trials

Written By: Derek Ansel, MS, CCRA, Executive Director, Therapeutic Strategy Lead, Rare Disease Given that 80% of rare diseases have a genetic etiology, genetic implications should be addressed at the onset of a clinical program to support trial enrollment. One diagnostic example that I discussed in my presentation is autism.

Genetics 189
article thumbnail

Scientists develop genetic ‘monitors’ that detect when genes are active

Scienmag

New genetic sensors, developed by scientists at University of Warwick and Keele University, could function as a lab test device and even as a live monitoring system inside living cells The innovative system can detect when a specific gene in a cell is active – instead of only detecting its presence The technology is based […].

article thumbnail

Innovation in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

Given the complexity and widespread impact of autoimmune and bone health conditions, developing new therapies is essential. This shift in therapeutic strategies brings hope to millions of patients, but it also results in challenges in developing therapies that work across different populations.

Research 147
article thumbnail

STAT+: On the long road to treating Huntington’s genetic stutter, scientists return to overlooked clues

STAT News

The scientists sent the blood 950 miles east to Massachusetts General Hospital in Boston, to a tiny lab (recently converted from a storeroom) where a 28-year-old postdoc named James Gusella and his 23-year-old research technician, Rudolph Tanzi, got to work.

Genetics 111
article thumbnail

Scientists develop mouse model to study mpox virulence

Medical Xpress

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have removed a major roadblock to better understanding of mpox (formerly, monkeypox).